VSV Purification via Anion Exchange Membrane Adsorption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying vesicular stomatitis virus (VSV) from mammalian cell culture fluids are inefficient in achieving high purity and yield, due to challenges with removing cell culture contaminants and the high cost of scaling up existing purification processes such as sucrose gradient ultracentrifugation and affinity chromatography.

Innovation Solution

A novel purification process involving primary clarification by low-speed centrifugation or depth filtration, followed by secondary clarification through microfiltration, anion exchange membrane adsorption, tangential flow filtration, and final filtration using a 0.2 to 0.22 µm filter, which effectively removes contaminants and enhances VSV recovery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If sucrose gradient ultracentrifugation is used for VSV purification, then virus separation is achieved, but the process becomes extremely costly to scale-up and fails to effectively remove cell debris, host DNA and protein impurities at higher virus concentrations

Engineering Contradiction:
Improvepurification effectivenessVSAvoidscalability and cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The purification process is divided into multiple discrete steps: low-speed centrifugation for primary clarification, microfiltration for secondary clarification, anion exchange membrane adsorption for viral particle separation, and tangential flow filtration for concentration and buffer exchange. This segmentation allows each step to be optimized independently and enables effective purification at scale unlike the single-step sucrose gradient method

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Anion exchange membrane adsorption serves as an intermediary step between clarification and final filtration. The membrane selectively adsorbs viral particles based on their negative charge, separating them from cell debris and proteins while maintaining scalability. This intermediary mechanism provides both purification effectiveness and manufacturing feasibility

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If polyethylene glycol (PEG) precipitation is used for VSV concentration and purification, then virus concentration is achieved, but similar problems occur with high impurity levels and difficulty in removing cell culture contaminants

Engineering Contradiction:
Improvevirus concentrationVSAvoidpurity level
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent replaces the chemical precipitation mechanism of PEG with a physical separation mechanism using anion exchange membrane adsorption. The membrane's selective permeability and charge-based interaction with viral particles enables concentration and purification simultaneously, removing contaminants that PEG precipitation cannot effectively eliminate

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The process utilizes changes in ionic strength and pH parameters during membrane adsorption to optimize viral particle binding and elution. By adjusting these parameters, the system achieves both high virus concentration and high purity, overcoming the limitations of PEG precipitation

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If increased cell concentrations and longer culture times are used in bioreactor-based processes, then VSV titer increases, but cell debris and concentrations of organic constituents increase, further complicating VSV purification processes

Engineering Contradiction:
ImproveVSV titerVSAvoidpurification process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The process performs preliminary clarification actions before the main purification step. Low-speed centrifugation removes cell debris and unlysed cells, while microfiltration removes remaining particulate matter. This preliminary action simplifies the subsequent membrane adsorption and filtration steps, making the overall process less complex even at high cell concentrations

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The anion exchange membrane selectively extracts and removes viral particles from the cell culture supernatant based on their electrical charge properties. This extraction mechanism is effective at high virus titers and simultaneously removes co-purifying contaminants, reducing process complexity compared to conventional methods

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves VSV purification with greater than 99.8% removal of cell culture protein and nucleic acid contaminants, improving yield and purity while reducing operational costs compared to traditional methods.

Implementation Method 1

anion exchange membrane adsorption

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 2

tangential flow filtration

Methodology Applied
Scientific EffectFiltration: Filter (physical)

Data Source

PatentEP2007883B1Purification processes for isolating purified vesicular stomatitis virus from cell culture
Publication Date: 2011.12.28 WYETH LLC
  • EP2007883B1 patent drawingFigure 1
  • EP2007883B1 patent drawingFigure 2A~2B
  • EP2007883B1 patent drawingFigure 3A~3B

AI summary

Novel purification processes for obtaining vesicular stomatitis virus (VSV) of improved purity from mammalian cell culture are described herein. More particularly, in certain embodiments, a process is described for purifying VSV from cell culture fluid of a mammalian cell culture infected with VSV, the process comprising: clarifying the cell culture fluid by low-speed centrifugation and recovering the VSV in the supernatant; filtering the supernatant through a 0.2 to 0.45 µm filter and recovering the VSV in the filtered solution; loading the VSV filtered solution onto a anion exchange membrane adsorber equilibrated with a first pH buffered salt solution, eluting the VSV from the anion exchange membrane adsorber with a second pH buffered salt solution and recovering the eluted VSV fractions; purifying the recovered VSV by tangential flow filtration (TFF) using a TFF membrane having a molecular weight cutoff between 300 kDa and 1,000 kDa and recovering the VSV in the retentate, and filtering the VSV retentate through a 0.2 to 0.22 µm filter and recovering the VSV in the filtered solution.